Article By:
Zacks Investment Research
Saturday, September 5, 2020 5:50 PM EDT
Novavax (NVAX) is a formidable name in the list of companies who are working on a vaccine. The company’s shares have gained 2487.4% this year. Let’s look at ETFs with the highest exposure to Novarax that can gain on the positive development,
